Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton recall — FDA D-1152-2022
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Overview of recall records associated with Mayne Pharma Inc., including dates, categories and classifications where available.
Classification mix: Class II: 1.
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
This page summarizes recall records in which the official source identifies Mayne Pharma Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.